
|Videos|July 3, 2015
What is the Future of Biosimilars?
Author(s)Davy James, Managing Editor
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Advertisement
CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
3
Ensitrelvir Demonstrates Significant COVID-19 Post-Exposure Prophylaxis Efficacy in Phase 3 Trial
4
Insulin Deprescribing Utilizing Continuous Glucose Monitoring With Low-Dose Tirzepatide
5



































































































































